Treatment of primary cancers of the pleura

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 4505, A61K 3702

Patent

active

052195651

ABSTRACT:
A method for treating primary cancers of the pleura in humans comprising administering to humans an amount of a polyprotein having human interleukin activity sufficient to treat primary cancers of the pleura.

REFERENCES:
Stedman's Medical Dictionary 24th edition (1982) pp. 216, 707-708, 829 & 1100.
Yasumoto et al. Cancer Research 47, Apr. 19, 1987 pp. 2184-2187.
Kato et al. Biochem. & Biophys. Research Comm. vol. 130, No. 2, 1985 pp. 692-699.
Thatcher et al. Cancer Treatment Reviews vol. 16, SupA. pp. 161-162, 1989.
Flechter, et al., Lymphokine Research, vol. 6 (1987) pp. 45 to 57.
Rosenberg, et al, N. Eng. J. Med., vol. 316 (1987) pp. 889 to 897.
Antman, N. Eng. J. Med., vol. 303 (1980) pp. 200 to 202.
Antman, Am. J. Med., vol. 68 (1980) pp. 356 to 362.
Manning et al., Am. Rev. Respir. Dis., (Abstract only).
Bradley et al, 3rd Int. Conference on Malignant Lymphona Jun. 19, 1987 p. 87.
Taniguchi et al., Nature, vol. 302 (1983) pp. 305 to 306.
Ju et al., J. Biol. Chem (1987), vol. 262 pp. 5723 to 5731.
Mossman et al., Immunol. Meth (1983), vol. 65, pp. 55 to 63.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of primary cancers of the pleura does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of primary cancers of the pleura, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of primary cancers of the pleura will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1040801

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.